GRUPO DE EPIDEMIOLOGÍA AMBIENTAL Y MOLECULAR
GEPIMOL
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (22)
2023
-
A multivariable prediction model for intra-amniotic infection in patients with preterm labor and intact membranes including a point of care system that measures amniotic fluid MMP-8
Journal of Perinatal Medicine
-
Noninvasive prediction models of intra-amniotic infection in women with preterm labor
American Journal of Obstetrics and Gynecology, Vol. 228, Núm. 1, pp. 78.e1-78.e13
2020
-
ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort
Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 140-148
2019
-
Alkylphenolic compounds and risk of breast and prostate cancer in the MCC-Spain study
Environment International, Vol. 122, pp. 389-399
2018
-
Preliminary safety results of the randomized phase II ABIDO-SOGUG trial: Toxicity profile of concomitant abiraterone acetate + docetaxel treatment in comparison to docetaxel
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii286
-
Radium-223 international early access program: Results from the Spanish subset
Future Oncology, Vol. 14, Núm. 1, pp. 41-50
2017
-
Helicobacter pylori antibody reactivities and colorectal cancer risk in a case-control study in Spain
Frontiers in Microbiology, Vol. 8, Núm. MAY
2016
-
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
BMC Cancer, Vol. 16, Núm. 1
-
Ingested nitrate and breast cancer in the Spanish multicase-control study on cancer (MCC-Spain)
Environmental Health Perspectives, Vol. 124, Núm. 7, pp. 1042-1049
2015
-
Chemotherapy-associated anemia in patients with lung cancer: An epidemiological, retrospective and multicenter study
Future Oncology, Vol. 11, Núm. 11, pp. 1665-1674
-
Hormonal contraception and postmenopausal hormone therapy in Spain: Time trends and patterns of use
Menopause, Vol. 22, Núm. 10, pp. 1138-1146
-
Management of the adverse events of afatinib: A consensus of the recommendations of the Spanish expert panel
Future Oncology, Vol. 11, Núm. 2, pp. 267-277
2014
2013
-
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
British Journal of Cancer, Vol. 109, Núm. 1, pp. 121-130
-
Dolor como factor predictor de depresión en el paciente oncológico: estudio de casos y controles. Estudio D-PRESS
Revista de la Sociedad Espanola del Dolor, Vol. 20, Núm. 3, pp. 113-121
-
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma
Annals of Oncology, Vol. 24, Núm. 9, pp. 2409-2414
-
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572
2012
-
Prácticas de cribado de cáncer y estilos de vida asociados en la población de controles del estudio español multi-caso control (MCC-Spain)
Gaceta Sanitaria, Vol. 26, Núm. 4, pp. 301-310
2011
-
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: A multicentre, observational, prospective study
The Lancet Oncology, Vol. 12, Núm. 12, pp. 1143-1150
2007
-
Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas
Cancer Chemotherapy and Pharmacology, Vol. 59, Núm. 2, pp. 251-259